Literature DB >> 30056204

Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour.

Jessica M Rosin1, Siddharth R Vora2, Deborah M Kurrasch3.   

Abstract

Microglia are the resident immune cells in the central nervous system (CNS). Originally thought to be primarily responsible for disposing of cellular debris and responding to neural insults, emerging research now shows that microglia are highly dynamic cells involved in a variety of neurodevelopmental processes. The hypothalamus is a brain region critical for maintaining homeostatic processes such as energy balance, thirst, food intake, reproduction, and circadian rhythms. Given that microglia colonize the embryonic brain alongside key steps of hypothalamic development, here we tested whether microglia are required for the proper establishment of this brain region. The Colony-stimulating factor-1 receptor (Csf1r) is expressed by microglia, macrophages and osteoclasts, and is required for their proliferation, differentiation, and survival. Therefore, to eliminate microglia from the fetal brain, we treated pregnant dams with the CSF1R inhibitor PLX5622. We showed that approximately 99% of microglia were eliminated by embryonic day 15.5 (E15.5) after pregnant dams were placed on a PLX5622 diet starting at E3.5. Following microglia depletion, we observed elevated numbers of apoptotic cells accumulating throughout the developing hypothalamus. Once the PLX5622 diet was removed, microglia repopulated the postnatal brain within 7 days and did not appear to repopulate from Nestin+ precursors. Embryonic microglia depletion also resulted in a decreased litter size, as well as an increase in the number of pups that died within the first two postnatal days of life. In pups that survived, the elimination of microglia in the fetal brain resulted in a decrease in the number of Pro-opiomelanocortin (POMC) neurons and a concomitant accelerated weight gain starting at postnatal day 5 (P5), suggesting that microglia could be important for the development of cell types key to hypothalamic satiety centers. Moreover, surviving PLX5622 exposed animals displayed craniofacial and dental abnormalities, perhaps due to non-CNS effects of PLX5622 on macrophages and/or osteoclasts. Finally, depletion of microglia during embryogenesis had long-term sex-specific effects on behaviour, including the development of hyperactivity and anxiolytic-like behaviour in juvenile and adult female mice, respectively. Together, these data demonstrate an important role for microglia during the development of the embryonic hypothalamus, and perhaps the CNS more broadly.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Embryonic development; Hyperactivity; Hypothalamus; Microglia; POMC neurons; Weight gain

Mesh:

Substances:

Year:  2018        PMID: 30056204     DOI: 10.1016/j.bbi.2018.07.023

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  22 in total

1.  Lack of Flvcr2 impairs brain angiogenesis without affecting the blood-brain barrier.

Authors:  Nicolas Santander; Carlos O Lizama; Eman Meky; Gabriel L McKinsey; Bongnam Jung; Dean Sheppard; Christer Betsholtz; Thomas D Arnold
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Temporal profile of serum metabolites and inflammation following closed head injury in rats is associated with HPA axis hyperactivity.

Authors:  Palkin Arora; Kavita Singh; Megha Kumari; Richa Trivedi
Journal:  Metabolomics       Date:  2022-04-29       Impact factor: 4.290

3.  Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622.

Authors:  Yong Yang; Tamaki Ishima; Xiayun Wan; Yan Wei; Lijia Chang; Jiancheng Zhang; Youge Qu; Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-04       Impact factor: 5.270

4.  The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model.

Authors:  Eri Iwasawa; Farrah N Brown; Crystal Shula; Fatima Kahn; Sang Hoon Lee; Temugin Berta; David R Ladle; Kenneth Campbell; Francesco T Mangano; June Goto
Journal:  J Neurosci       Date:  2022-01-06       Impact factor: 6.709

Review 5.  To Kill a Microglia: A Case for CSF1R Inhibitors.

Authors:  Kim N Green; Joshua D Crapser; Lindsay A Hohsfield
Journal:  Trends Immunol       Date:  2020-08-10       Impact factor: 16.687

6.  Specific depletion of resident microglia in the early stage of stroke reduces cerebral ischemic damage.

Authors:  Ting Li; Jin Zhao; Wenguang Xie; Wanru Yuan; Jing Guo; Shengru Pang; Wen-Biao Gan; Diego Gómez-Nicola; Shengxiang Zhang
Journal:  J Neuroinflammation       Date:  2021-03-23       Impact factor: 8.322

7.  Role of microglia in the dissemination of Zika virus from mother to fetal brain.

Authors:  Pei Xu; Chao Shan; Tiffany J Dunn; Xuping Xie; Hongjie Xia; Junling Gao; Javier Allende Labastida; Jing Zou; Paula P Villarreal; Caitlin R Schlagal; Yongjia Yu; Gracie Vargas; Shannan L Rossi; Nikolaos Vasilakis; Pei-Yong Shi; Scott C Weaver; Ping Wu
Journal:  PLoS Negl Trop Dis       Date:  2020-07-06

8.  Hydrogen Sulfide Reverses LPS-Induced Behavioral Deficits by Suppressing Microglial Activation and Promoting M2 Polarization.

Authors:  Mohit Kumar; Palkin Arora; Rajat Sandhir
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-16       Impact factor: 4.147

9.  Embryonic microglia influence developing hypothalamic glial populations.

Authors:  Candace M Marsters; Dinushan Nesan; Rena Far; Natalia Klenin; Quentin J Pittman; Deborah M Kurrasch
Journal:  J Neuroinflammation       Date:  2020-05-06       Impact factor: 8.322

Review 10.  Microglia in the developing retina.

Authors:  Fenge Li; Danye Jiang; Melanie A Samuel
Journal:  Neural Dev       Date:  2019-12-30       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.